- Home
- MRK vs LBRDP Comparison
MRK vs LBRDP Comparison
Compare MRK & LBRDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- LBRDP
- Stock Information
- Founded
- MRK 2000
- LBRDP N/A
- Country
- MRK United States
- LBRDP United States
- Employees
- MRK N/A
- LBRDP 1900
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- LBRDP Cable & Other Pay Television Services
- Sector
- MRK Health Care
- LBRDP Telecommunications
- Exchange
- MRK Nasdaq
- LBRDP Nasdaq
- Market Cap
- MRK 218.8B
- LBRDP N/A
- IPO Year
- MRK N/A
- LBRDP N/A
- Fundamental
- Price
- MRK $87.39
- LBRDP $24.85
- Analyst Decision
- MRK Buy
- LBRDP
- Analyst Count
- MRK 15
- LBRDP 0
- Target Price
- MRK $105.14
- LBRDP N/A
- AVG Volume (30 Days)
- MRK 12.7M
- LBRDP N/A
- Earning Date
- MRK 10-30-2025
- LBRDP N/A
- Dividend Yield
- MRK 3.70%
- LBRDP N/A
- EPS Growth
- MRK 20.41
- LBRDP N/A
- EPS
- MRK 6.49
- LBRDP N/A
- Revenue
- MRK $63,616,000,000.00
- LBRDP N/A
- Revenue This Year
- MRK $1.84
- LBRDP N/A
- Revenue Next Year
- MRK $5.24
- LBRDP N/A
- P/E Ratio
- MRK $13.51
- LBRDP N/A
- Revenue Growth
- MRK 1.82
- LBRDP N/A
- 52 Week Low
- MRK $73.31
- LBRDP N/A
- 52 Week High
- MRK $109.17
- LBRDP N/A
- Technical
- Relative Strength Index (RSI)
- MRK 58.96
- LBRDP 57.76
- Support Level
- MRK $83.16
- LBRDP $24.42
- Resistance Level
- MRK $85.50
- LBRDP $24.53
- Average True Range (ATR)
- MRK 1.77
- LBRDP 0.17
- MACD
- MRK -0.02
- LBRDP 0.03
- Stochastic Oscillator
- MRK 53.87
- LBRDP 78.05
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About LBRDP Liberty Broadband Corporation Series A Cumulative Redeemable Preferred Stock
Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.